Protein Information

ID 81
Name protein kinase C (protein family or complex)
Synonyms Protein kinase C; PKC

Compound Information

ID 332
Name 4-aminopyridine
CAS 4-pyridinamine

Reference

PubMed Abstract RScore(About this table)
10884519 Ko WH, Yao XQ, Lau CW, Law WI, Chen ZY, Kwok W, Ho K, Huang Y: Vasorelaxant and antiproliferative effects of berberine. . Eur J Pharmacol. 2000 Jul 7;399(2-3):187-96.
The present study was intended to examine the relaxant effects of berberine in rat isolated mesenteric arteries. Berberine produced a rightward shift of the concentration-response curve to phenylephrine and significantly reduced the maximal contractile response to phenylephrine. Berberine (10 (-7)-3x10 (-5) M) also relaxed the phenylephrine- and 9,11-dideoxy-11alpha, 9alpha-epoxy-methanoprostaglandin F (2alpha)-precontracted arteries with respective IC (50) values of 1.48+/-0.16x10 (-6) and 2.23+/-0. 22x10 (-6) M. Removal of a functional endothelium significantly attenuated the berberine-induced relaxation (IC (50): 4.73+/-0. 32x10 (-6) M) without affecting the maximum relaxant response. Pretreatment with N (G)-nitro-L-arginine methyl ester (L-NAME) or methylene blue reduced the relaxant effect of berberine, and L-arginine (10 (-3) M) partially antagonized the effect of L-NAME. In contrast, pretreatment with 10 (-6) M glibenclamide or 10 (-5) M indomethacin had no effect. Berberine (10 (-5) M) reduced over by 50% the transient contraction induced by caffeine or phenylephrine in endothelium-denuded rings bathed in Ca (2+)-free Krebs solution. Pretreatment with putative K (+) channel blockers, such as tetrapentylammonium ions (1-3x10 (-6) M), 4-aminopyridine (10 (-3) M), or Ba (2+) (3x10 (-4) M), significantly attenuated the berberine-induced relaxation in endothelium-denuded arteries. In contrast, tetraethylammonium ions (3x10 (-3) M), charybdotoxin (10 (-7) M) or glibenclamide (10 (-6) M) were without effect. Berberine reduced the high-K (+)-induced sustained contraction and the relaxant response to berberine was greater in rings with endothelium (IC (50): 4.41+/-0.47x10 (-6) M) than in those without endothelium (IC (50): 8.73+/-0.74x10 (-6) M). However, berberine (10 (-6)-10 (-4) M) did not affect the high-K (+)-induced increase of intracellular [Ca (2+)] in cultured aortic smooth muscle cells. Berberine did not affect active phorbol ester-induced contraction in Ca (2+)-free Krebs solution. In addition, berberine inhibited proliferation of cultured rat aortic smooth muscle cells with an IC (50) of 2.3+/-0.43x10 (-5) M. These findings suggest that berberine could act at both endothelium and the underlying vascular smooth muscle to induce relaxation. Nitric oxide from endothelium may account primarily for the berberine-induced endothelium-dependent relaxation, while activation of tetrapentylammonium-, 4-aminopyridine- and Ba (2+)-sensitive K (+) channels, inhibition of intracellular Ca (2+) release from caffeine-sensitive pools, or a direct relaxant effect, is likely responsible for the berberine-induced endothelium-independent relaxation. Mechanisms related to either Ca (2+) influx or protein kinase C activation may not be involved. Both vasorelaxant and antiproliferative effects may contribute to a long-term benefit of berberine in the vascular system.
0(0,0,0,0)